Cargando…

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany

PURPOSE: Asthma is one of the most prevalent chronic diseases in Germany affecting 4–5% of all adults and 10% of children. Despite the availability of biologicals in recent years, studies show patients with inadequately controlled severe asthma in real life. The aim of the current study was to chara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergmann, Karl-Christian, Skowasch, Dirk, Timmermann, Hartmut, Lindner, Robert, Virchow, Johann Christian, Schmidt, Olaf, Koschel, Dirk, Neurohr, Claus, Heck, Sebastian, Milger, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270010/ https://www.ncbi.nlm.nih.gov/pubmed/35815115 http://dx.doi.org/10.2147/JAA.S365967

Ejemplares similares

Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
por: Timmermann, Hartmut, et al.
Publicado: (2023)

Two cheers for GINA?
por: McGuire, Amy L, et al.
Publicado: (2009)

Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS)
por: Milger, Katrin, et al.
Publicado: (2023)

Die NVL Depression benötigt mutigere und differenziertere Aussagen zur Psychotherapie
por: Rief, Winfried, et al.
Publicado: (2022)

Gina DeNicola: In vivo veritas
por: Morgado-Palacin, Lucia
Publicado: (2023)

Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
por: Suhling, Hendrik, et al.
Publicado: (2023)

Disparate impacts and GINA: Congress's unfinished business
por: Wagner, Jennifer K
Publicado: (2019)

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
por: Drilon, Alexander, et al.
Publicado: (2023)

Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines
por: Horak, Fritz, et al.
Publicado: (2016)

Small Airways: The “Silent Zone” of 2021 GINA Report?
por: Cottini, Marcello, et al.
Publicado: (2022)

Symptom versus exacerbation control: an evolution in GINA guidelines?
por: Latorre, Manuela, et al.
Publicado: (2023)

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
por: Korn, Stephanie, et al.
Publicado: (2023)

The GINA asthma strategy report: what’s new for primary care?
por: Reddel, Helen K, et al.
Publicado: (2015)

GiNA, an Efficient and High-Throughput Software for Horticultural Phenotyping
por: Diaz-Garcia, Luis, et al.
Publicado: (2016)

Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthma
por: Singh, Dave, et al.
Publicado: (2023)

A summary of the new GINA strategy: a roadmap to asthma control
por: Reddel, Helen K., et al.
Publicado: (2015)

Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam
por: Nguyen, Vinh Nhu, et al.
Publicado: (2017)

GINA at 10 years: the battle over ‘genetic information’ continues in court
por: Suter, Sonia M
Publicado: (2019)

Classification of asthma according to revised 2006 GINA: Evolution from severity to control
por: Koshak, Emad A.
Publicado: (2007)

How does the GINA definition of control correlate with quality of life and sputum cellularity?
por: Pizzichini, Marcia Margaret Menezes, et al.
Publicado: (2019)

It is time to change the way we manage mild asthma: an update in GINA 2019
por: Muneswarao, Jaya, et al.
Publicado: (2019)

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020)

Will the clinical development of 4th-generation “double mutant active” ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2021)

Keeping the GINA in the bottle: assessing the current need for genetic non-discrimination legislation in Canada
por: Pullman, Daryl, et al.
Publicado: (2010)

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy
por: Brusselle, Guy, et al.
Publicado: (2017)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
por: Cruz, Álvaro A., et al.
Publicado: (2021)

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
por: Levy, Mark L., et al.
Publicado: (2023)

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
por: Kreuter, Michael, et al.
Publicado: (2019)

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
por: Kreuter, Michael, et al.
Publicado: (2017)

Incidence, causes, and predictors of unsuccessful decannulation following prolonged weaning
por: Ghiani, Alessandro, et al.
Publicado: (2022)

The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma
por: Lim, So Yeon, et al.
Publicado: (2014)

Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?
por: Abuzakouk, Mohamed, et al.
Publicado: (2020)

The mechanical characteristics and performance evaluation of a newly developed silicone airway stent (GINA stent)
por: Jung, Hwa Sik, et al.
Publicado: (2021)

Maternal outcome after abdominal packing for uncontrolled postpartum hemorrhage despite peripartum hysterectomy
por: Deffieux, Xavier, et al.
Publicado: (2017)

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
por: Behr, Jürgen, et al.
Publicado: (2015)

Asthma in pregnancy: association of asthma control test (ACT) with clinical management by the global initiative for asthma (GINA)
por: Araujo, Georgia, et al.
Publicado: (2015)

COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)

Improvement in symptoms and pulmonary function of asthmatic patients due to their treatment according to the Global Strategy for Asthma Management (GINA)
por: Boskabady, Mohammad H, et al.
Publicado: (2008)

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
por: van Zyl-Smit, Richard N., et al.
Publicado: (2023)

Chronic cough in Germany: results from a general-population survey
por: Virchow, J. Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ca8mu1q53anl5kiq64969uj8ki